Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration

PURPOSE To describe two patients with Behçet's disease who underwent cataract surgery one week after infliximab administration. METHODS Patients received preoperative antibiotic therapy with 0.5% levofloxacin eye drops and 500 mg levofloxacin oral tablets, followed by cataract surgery one week after infliximab administration. We observed ocular findings following cataract surgery, phacoemulsification-aspiration, and posterior chamber intraocular lens implantation. RESULTS There were no intraoperative complications. Neither ocular inflammatory attacks nor infectious complications were found in the operated eyes of both patients during follow-up. CONCLUSION Administration of infliximab one week before cataract surgery is safe and effective for patients with Behçet's disease.